Biotech China 2014

Drug Design: Genentech

Total Score People Score Events Score
47 42 36
Date Event Presentation Speakers
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference Enzyme regulatory mechanisms of USP7 James Ernst
May 20, 2010 Bioanalytical Challenges for Optimizing Protein Therapeutics Free vs. Total Ligand Binding Assays: Points to Consider in Drug Development Jihong Yang
Immunogenicity: Regulatory and Technical Overview with Case Studies of Assay Challenges Eric Wakshull
May 19, 2010 Pre-Clinical / Clinical Development of Therapeutic Antibodies Recommendations for Nonclinical PK Comparability Study Designs for Monoclonal Antibodies Wendy Putnam
May 19, 2010 Towards Personalized Cancer Medicine Role of the Microenvironment in VEGF-Independent Angiogenesis Napoleone Ferrara
November 3, 2009 ASAP-CHI Bio-Pharma Alliance Summit, Driving success with Effect ive Biotech/ Pharma Alliances “Getting it Right”: Genentech and UCSF’s Partnership in Asthma – Making Academic/Pharm Partnerships Work Ashraf Hanna
August 5, 2009 New Frontiers in Cancer Drug Development Cancer Stem Cells Chia Portera
Targeting the Hedgehog Pathway in Cancer Treatment Chia Portera
Bevacizumab in Patients with Previously Treated Glioblastoma Asha Das
August 3, 2009 The Next Wave of Antibody Therapeutics Antibody-Drug Conjugates for Cancer Therapy Paul G. Polakis
Clinical Results of the Phase I and Phase II Studies of Trastuzumab-DM1, A First-in-class HER2 Antibody-Drug Conjugate, in Patients with HER2+ Metastatic Breast Cancer Barbara Klencke
June 16, 2009 7th Annual Comparability for Biologics Selection of acceptance criteria for comparability studies throughout the development lifecycle Wassim Nashabeh
Regulatory expectations in the US for demonstrating comparability of biotechnology products Earl Dye
June 9, 2009 RNAi for Target Identification and Validation Unlocking the Genome with Pooled shRNA Screens David P. Davis
June 9, 2009 Translating Genomic Knowledge Genomic Tools in Identifying Markers of Resistance: ABCC3 Co-Amplification in HER2 Positive Breast Cancer Ajay Pandita
June 8, 2009 RNAi for Functional Screens Probing the p53 Pathway Laura Corson
OPTIMIZING RNAi DELIVERY FOR IN VITRO APPLICATIONS David P. Davis
May 11, 2009 Patient Recruitment in Clinical Trials Recruitment Planning Starts Earlier Than You Think Katherine Valentine
April 7, 2009 Inaugural Fragment-Based Techniques Use of SPR for Fragment Screening, HTS Hit Validation, and SAR Support in Drug Discovery Tony M. Giannetti
Topic 3: How to choose the right fragments to move forward Tony M. Giannetti
March 17, 2009 Bio Medical Asia 2009 Opening keynote: Leadership, innovation and efficiency: Key success factors of biomanufacturing Patrick , Yang
Managing the bottleneck in downstream processing: Matching the manufacturing capacity with upstream yield Brian Kelley
The Biotech Manufacturing World is Flat Patrick , Yang
March 10, 2009 7th Annual In-House Counsel Forum on Government Regulation of Prescription Drug Pricing Navigating Compliance Obligations Under New TRICARE Regulations Howard Crawford
March 3, 2009 2nd annual Competitive Intelligence in Pharma Roundtable sessions : Gathering and implementing CI information in early clinical development Deborah Dauber
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Session 5: Chemistry in Support of Lead Optimization/Case Histories I James Marsters
February 4, 2009 Adaptive Designs in Clinical Drug Development STRATEGIES AND PRACTICAL CONSIDERATIONS FOR ORPHAN DRUG DEVELOPMENT WITH ADAPTIVE DESIGN David Zhang
January 26, 2009 Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
January 26, 2009 Biomarker Assay Development Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
January 26, 2009 Translational Cancer Medicine Preclinical Biomarker Discovery and Validation for a Small Molecule Inhibitor of MEK Kinase Mark R Lackner
January 26, 2009 7th Annual Partnering with Central Labs B1 : How to Reduce the Burden on Smaller Sponsor Clinical Team-The Cross Functional Approach Rhonda Benotti
Track A : Best Practices for Collecting and Integrating Data in International Clinical Trials Elena Gogoleva
January 5, 2009 High Content Analysis Chemical Reporters for Probing and Visualizing Lipoproteins and Lipids in Cells Rami Hannoush
Utility of Time-Resolved Binding Date for Fragment-Based Screening and HTS Hit Validation Using SPR Biosensors Anthony M Giannetti
Profiling p53 Networks by Cell-Based Multiplex Imaging Rami Hannoush
November 17, 2008 BIO-Europe 2008 Maximizing Your Deal: The Business Case for Translational Medicine in Oncology Aron Knickerbocker
November 12, 2008 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Factoring Takeaways from Recent Deals and Trends into Your Collaborations Strategy Michael Crowley
November 11, 2008 Stability Testing for Biologics KEYNOTE - Novel techniques: Acceleration of protein degradation at high concentration Jun Liu
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Protein Metabolism/catabolism in the Disposition of Protein Therapeutics Paul J. Fielder
Optimizing ADME/PK Properties of Biotherapeutics Lisa Damico
Establishing the First in Human Dose for Biotherapeutics Jennifer E. Visich
July 19, 2008 22nd Annual Symposium of The Protein Society Concurrent Afternoon Symposia 9: New Methods for Engineering Recognition Sachdev Sidhu
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Panel Discussion David P Schenkein
Proof of Concept to the Drug Developer David P Schenkein
Panel Discussion David P Schenkein
May 30, 2008 ASCO Annual'08 Meeting professional development-- Contract Negotiations for Your First Job in Industry, Private Practice, or Academia Sean P. Bohen
April 28, 2008 Clinical Development of Therapeutic Antibodies The Development of Antiangiogenics in Lung Cancer Jane Huang
March 25, 2008 CYTOKINE-BASED THERAPEUTICS Preclinical Studies of Anti-OX40L in TH2-Driven Diseases Sarah Hymowitz
Title to Be Determined Vishva M. Dixit
December 3, 2007 PharmSep Modern HPLC Method Development: Fundamentals, Advances, and Best Practice Michael W. Dong
December 3, 2007 Pharma Sep Modern HPLC Method Development: Fundamentals, Advances, and Best Practice Michael W. Dong
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 7: Anti-Cancer/Tumors Drug Discovery & Development and Current Status of the Innovative Therapeutics (Part II) (09:00-12:00) Mark S. Dennis
Session 7: Tumor Targeting with an AB.Fab (09:00-09:20) Mark S. Dennis
November 5, 2007 Bio-Pharma Alliance Summit Nov (05-06) The Role of Alliance Management in Creating Successful Collaborations at Genentech (10:50-11:30) Ashraf Hanna
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.